Labcorp Net Change in Short-term Investments 2010-2025 | LH
Labcorp annual/quarterly net change in short-term investments history and growth rate from 2010 to 2025. Net change in short-term investments can be defined as the net cash flows from the sale and purchase of investments defined to be short-term, generally with maturities of less than one year from the purchase date.
- Labcorp net change in short-term investments for the quarter ending March 31, 2025 was $0M, a 0% increase year-over-year.
- Labcorp net change in short-term investments for the twelve months ending March 31, 2025 was $-55M, a 89.66% increase year-over-year.
- Labcorp annual net change in short-term investments for 2024 was $-0.055B, a 89.66% increase from 2023.
- Labcorp annual net change in short-term investments for 2023 was $-0.029B, a 66.67% increase from 2022.
- Labcorp annual net change in short-term investments for 2022 was $-0.017B, a 37.41% decline from 2021.
Labcorp Annual Net Change in Short-term Investments
(Millions of US $) |
| 2024 |
$-55 |
| 2023 |
$-29 |
| 2022 |
$-17 |
| 2021 |
$-28 |
| 2020 |
$-40 |
| 2019 |
$-28 |
| 2018 |
$-22 |
| 2017 |
$-36 |
| 2016 |
$14 |
| 2015 |
$8 |
| 2014 |
$N/A |
| 2013 |
$8 |
| 2012 |
$N/A |
| 2011 |
$N/A |
| 2010 |
$N/A |
| 2009 |
$N/A |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$20.926B |
$13.009B |
|
Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
|
